STE Eye Irritation Test: In Vitro Ocular Toxicity Assessment Based on OECD Test Guideline 491

The STE (Short Time Exposure) eye irritation test is an in vitro ocular toxicity method that evaluates the eye irritation potential of chemicals using cultured rabbit corneal cells. Recognized as OECD Test Guideline 491, this cell-based assay offers a rapid, humane, and cost-effective alternative to traditional animal testing. It is widely applied in the safety evaluation of cosmetics, household products, and industrial chemicals.

Technical Overview

The STE (Short Time Exposure) test is an in vitro eye irritation assay designed to assess the ocular irritation potential of chemical substances without the use of live animals. The method was developed by researchers in Japan and formally adopted by the OECD in 2015 as Test Guideline 491 (OECD TG 491). It is applicable to both liquid and solid test materials and supports the classification of substances under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).

The core principle of the STE test is based on the cytotoxic response of the SIRC cell line, a rabbit corneal epithelial cell line derived from the Statens Seruminstitut Rabbit Cornea. Because these cells retain characteristics of corneal epithelium, damage to their viability serves as a surrogate indicator of potential damage to the corneal surface in vivo. The test measures cell viability following a short, five-minute exposure period, which is designed to simulate the transient contact that occurs during accidental splash exposure to the eye.

Cell viability is quantified using a colorimetric endpoint, typically the MTT reduction assay, in which metabolically active cells convert the yellow tetrazolium dye into purple formazan crystals. The optical density of the dissolved formazan is measured spectrophotometrically, and the resulting viability values are compared against classification thresholds to categorize the test substance. Based on the viability results obtained from testing the neat substance and a 5% dilution, chemicals are classified into three outcomes: No Category (not requiring classification), Category 2 (eye irritation), or Category 1 (serious eye damage, irreversible effects on the eye).

• Test system: SIRC rabbit corneal epithelial cell line
• Exposure duration: 5 minutes
• Endpoint: cell viability measured by MTT assay
• Regulatory basis: OECD Test Guideline 491
• Classification output: GHS No Category, Category 2, or Category 1

Testing Samples

Cosmetics and Personal Care Products

Cosmetic formulations intended for use on or around the eye area, as well as rinse-off products that may accidentally contact the ocular surface, are routinely evaluated using the STE test. Typical sample types include eye creams, mascaras, eyeliners, facial cleansers, makeup removers, toners, serums, shampoos, conditioners, and body washes. Both finished formulations and individual raw materials, such as surfactants, preservatives, and plant extracts, can be submitted for assessment.

Household and Consumer Products

Household chemical products represent a major application area for the STE test. These include laundry detergents, dishwashing liquids, all-purpose cleaners, glass cleaners, bleach-based products, fabric softeners, and disinfectants. Because many of these products contain surfactants or other active ingredients with inherent irritation potential, the STE test provides a rapid screening tool to support formulation development and consumer safety assessment.

Industrial Chemicals and Agrochemicals

Industrial raw materials, intermediates, solvents, and agrochemical formulations may require eye hazard classification for transportation, workplace safety, and regulatory registration purposes. The STE test is suitable for classifying such substances under GHS when used within its applicability domain and in accordance with the integrated testing strategies defined by OECD guidance.

Other Sample Types

Additional sample categories suitable for STE evaluation include pharmaceutical excipients, medical device extracts (for devices with eye contact), veterinary products, and research compounds in early-stage development. Solid materials are tested as suspensions prepared in a suitable vehicle, typically at a defined concentration in physiological saline or culture medium, while liquids are tested both neat and diluted.

Testing Items

The primary testing item evaluated by the STE assay is the eye irritation potential of a test substance, expressed as a cytotoxicity-based viability measurement and an associated GHS classification. The specific deliverables of a standard STE study include:

• Cell viability following 5-minute exposure to the neat test substance
• Cell viability following 5-minute exposure to a 5% dilution of the test substance
• GHS classification outcome: No Category, Category 2, or Category 1
• Concurrent positive and negative control performance data
• Study report suitable for regulatory submission or internal safety documentation

For clients seeking more granular information, dose-response testing across a range of dilutions can be performed to estimate the concentration at which viability falls below the classification threshold, providing useful comparative data for formulation optimization and benchmarking against competitor or reference products.

Testing Methods

Test System Preparation

SIRC cells are cultured in Dulbecco's Modified Eagle Medium supplemented with fetal bovine serum under standard mammalian cell culture conditions. Cells are seeded into 96-well microplates and grown to a confluent monolayer, typically requiring overnight incubation at 37°C in a humidified atmosphere with 5% carbon dioxide. Only cultures demonstrating appropriate morphology, passage number within established limits, and freedom from contamination are used for testing.

Exposure Procedure

The exposure phase reflects the defining feature of the STE test: a brief five-minute contact time that models transient accidental ocular exposure. Liquid test substances are applied directly to the cell monolayer, either undiluted (neat) or as a 5% dilution in physiological saline. Solid substances are prepared as suspensions at a defined concentration in a suitable solvent. After the exposure period, the test substances are removed by thorough rinsing, and the cells are processed for viability determination. Testing is performed in replicate wells to ensure statistical reliability.

Viability Measurement

Following exposure and rinsing, cell viability is assessed using the MTT reduction assay. Viable cells with functional mitochondrial dehydrogenase activity convert MTT to insoluble formazan crystals, which are subsequently solubilized in a detergent or acidified alcohol solution. The absorbance of the resulting colored solution is measured at approximately 570 nm using a microplate reader. Viability is calculated as a percentage of the mean absorbance measured in the concurrent negative control wells, which is set at 100%.

Classification Criteria

The classification of the test substance is determined by combining the viability results from the neat and 5% dilution exposures according to the decision logic specified in OECD TG 491:

• Cell viability of 70% or less after exposure to the neat substance: classified as GHS Category 1 (serious eye damage)
• Cell viability above 70% after exposure to the neat substance combined with viability of 70% or less after exposure to the 5% dilution: classified as GHS Category 2 (eye irritation)
• Cell viability above 70% for both the neat substance and the 5% dilution: classified as No Category (not classified as an eye irritant)

Quality Control and Acceptance Criteria

Each test run includes a positive control, commonly a known irritant such as benzalkonium chloride, and a negative control, typically the vehicle or culture medium. The assay is considered valid only when the positive control produces viability values within the historical control range and the negative control maintains acceptable viability with limited variability among replicate wells. These controls ensure the sensitivity and reproducibility of the test system and support the regulatory defensibility of the results.

Applications

The STE test serves multiple purposes across product development, regulatory compliance, and safety assessment workflows. Its short exposure protocol and straightforward readout make it particularly valuable for high-throughput screening during early formulation development.

• Cosmetic safety assessment: supporting claims of mildness and demonstrating the ocular compatibility of eye-area products in alignment with animal testing bans in regions such as the European Union
• Regulatory classification: providing data for GHS labeling of chemicals, workplace hazard communication, and safety data sheet development
• Formulation optimization: comparing candidate formulations, evaluating ingredient substitutions, and guiding reformulation when irritation signals are detected
• Benchmarking: comparing the irritation profile of a product against reference or competitor formulations
• Integrated testing strategies: serving as a component within tiered ocular toxicity assessment approaches, often combined with methods such as BCOP, EpiOcular, or ICE depending on regulatory requirements
• Raw material screening: rapid evaluation of new ingredients prior to inclusion in product development pipelines

It should be noted that the STE test, like all in vitro methods, has defined limitations. It does not provide information on the reversibility of effects, does not assess corneal opacity or depth of injury in the manner of organotypic models, and may not be suitable for strongly colored, highly volatile, or highly reactive substances that interfere with the assay endpoint. Regulatory classification decisions may therefore require data from additional test methods used in combination.

FAQ

What does the STE in the STE test stand for?

STE stands for Short Time Exposure, referring to the brief five-minute exposure period that distinguishes this method from longer-duration cytotoxicity assays. The short exposure is intentionally designed to reflect the transient nature of accidental eye contact with chemicals in real-world scenarios.

Is the STE test recognized by regulatory authorities?

Yes. The STE test was formally adopted as OECD Test Guideline 491 in 2015 and is recognized by regulatory authorities in OECD member countries. It is accepted for use in the classification of eye irritation and serious eye damage within defined applicability domains, often as part of a broader integrated testing strategy rather than as a standalone replacement for all in vivo ocular toxicity endpoints.

How does the STE test differ from other in vitro eye irritation methods?

The STE test uses a two-dimensional rabbit corneal cell culture and measures cytotoxicity after a short exposure, making it fast, economical, and well suited for screening. In contrast, the BCOP test uses isolated bovine or porcine corneas and measures corneal opacity and permeability, while reconstructed human tissue models such as EpiOcular assess tissue-level viability over longer exposure periods. Each method occupies a different position within tiered testing strategies, and the appropriate choice depends on the substance type and the regulatory question being addressed.

What is the typical turnaround time for an STE test?

Because the assay relies on a cultured cell line with a short exposure period and a rapid colorimetric endpoint, a complete STE study, including repeat runs where required and final reporting, is typically completed within one to two weeks. This is considerably faster than tissue-based and organotypic methods, which often require longer lead times for model procurement and recovery assessments.

Can the STE test fully replace the traditional rabbit eye irritation test?

The STE test substantially reduces the need for animal testing and can fully replace animal use for certain classification purposes, particularly for identifying substances that do not require classification and for distinguishing between some irritant categories. However, no single in vitro method currently replicates all aspects of the in vivo rabbit eye test, so regulatory classification of certain substances may still require a weight-of-evidence approach combining multiple alternative methods and existing data.

What sample information should be provided when submitting a test request?

Clients should provide the sample name, physical form (liquid or solid), composition or ingredient list where available, known pH and solubility characteristics, and the intended purpose of testing, such as screening, claim support, or regulatory classification. This information allows the testing laboratory to select the appropriate preparation procedure, solvent system, and assay design in accordance with OECD TG 491 requirements.